HX GROUP(SH:600851)2016-10-27 16:00Financial Performance - Net profit attributable to shareholders increased by 25.04% to CNY 159,585,074.54 year-on-year[6] - Basic earnings per share increased by 25.07% to CNY 0.1322[6] - The company reported a 270.24% increase in received investment income to ¥82,369,459.69, driven by higher dividends from Changxin Fund and the sale of Changjiang Securities[14] - The net profit for the same period was CNY 173,058,592, representing a significant increase of 38.1% from CNY 125,358,410 in the previous year[30] - The total profit for Q3 2016 was ¥51,459,876.35, up from ¥37,036,764.68 in Q3 2015, marking a growth of 38.5%[26] - The company's operating profit for the third quarter was CNY 44,455,972, up 67.0% from CNY 26,602,631 in the same quarter last year[30] Revenue and Costs - Operating revenue decreased by 6.44% to CNY 733,341,669.89 compared to the same period last year[5] - Total operating revenue for Q3 2016 was ¥288,399,353.69, a decrease of 16.4% compared to ¥344,828,674.95 in Q3 2015[25] - Total operating costs for Q3 2016 were ¥294,377,114.85, down 12% from ¥334,174,109.45 in Q3 2015[26] - The company's operating revenue for the period from January to September was CNY 6,818,147,520, a decrease of 60.7% compared to CNY 17,380,210,310 in the same period last year[30] Assets and Liabilities - Total assets decreased by 6.45% to CNY 5,654,489,861.06 compared to the end of the previous year[5] - Total liabilities decreased from CNY 1,241,193,359.56 to CNY 1,131,699,248.06, showing a decline of around 8.9%[19] - Owner's equity decreased from CNY 4,803,149,103.54 to CNY 4,522,790,613.00, representing a decrease of about 5.8%[20] - Non-current assets totaled CNY 4,558,499,184.68, down from CNY 5,002,181,106.45, indicating a decrease of about 8.9%[18] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 66,424,883.40, an improvement from a net outflow of CNY 151,364,720.94 in the previous year[5] - The cash flow from investing activities generated a net inflow of CNY 146,140,010, compared to a net inflow of CNY 252,922,080 in the previous year[35] - The cash flow from financing activities resulted in a net outflow of CNY 65,258,281, an improvement from a net outflow of CNY 265,510,616 in the previous year[35] - The company's cash and cash equivalents at the end of the period totaled CNY 443,973,005, an increase from CNY 401,586,208 at the end of the previous year[35] Shareholder Information - The total number of shareholders reached 80,651, with 43,587 A-share holders and 37,064 B-share holders[10] - The company received a dividend of CNY 87,899,000 from Changjiang Securities, an increase of CNY 50,249,000 year-on-year[6] - The company sold 2.8 million shares of Changjiang Securities, generating an investment income of CNY 25,500,000, an increase of CNY 11,078,000 year-on-year[6] Investment Income - Investment income surged by 111.00% to ¥56,543,196.28, mainly from the sale of Changjiang Securities and increased returns from Suzhong Pharmaceutical[14] - Investment income for Q3 2016 was ¥56,543,196.28, an increase of 111.5% compared to ¥26,797,396.69 in Q3 2015[26] Other Financial Metrics - The weighted average return on net assets increased by 0.8491 percentage points to 3.6021%[6] - Financial expenses increased by 429.88% to ¥2,918,858.88, primarily due to reduced interest income and increased exchange losses[13] - The company experienced a 69.93% decrease in tax refunds received, totaling ¥1,900,700.31 compared to ¥6,320,167.08 in the previous year[14] - The company's total equity was ¥5,022,968,342.52, down from ¥5,299,173,430.48 year-over-year[25]